Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as well as their implications for other applications like kidney disease and ...

A new study published in the journal JAMA Psychiatry found that semaglutide (sold under brand names like Ozempic and Wegovy) ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

UW Health's Dr. Bill Hartman discusses a new study on Ozempic and alcohol cravings. For the first time since the start of the pandemic, flu deaths now outnumber COVID-19 deaths.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Cardiologists believe Ozempic and Wegovy could help prevent heart disease. Dr. Marc Gibber, medical director and chief of cardiothoracic surgery at Baptist Health Bethesda Hospital East, stopped by ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

One person is dead after a private jet owned by Mötley Crüe singer Vince Neil collided with another midsized jet Monday ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

The Hims & Hers version of the weight-loss drug is a compounded drug, essentially a mixture of individual drugs that creates ...